Alzheimer’s disease is one of the most feared illnesses of old age. It slowly destroys memory, thinking ability, and independence. As the disease progresses, people may struggle to remember family members, manage daily tasks, or even communicate clearly.
Eventually, the brain becomes so damaged that the body can no longer function normally. Because the disease develops slowly over many years, finding ways to detect it early has become one of the biggest goals in medical research.
Now scientists at Worcester Polytechnic Institute (WPI) have developed a new approach that may help doctors identify Alzheimer’s disease much earlier than before.
Using a form of artificial intelligence, the researchers were able to study detailed brain scans and predict the presence of Alzheimer’s disease with nearly 93 percent accuracy. Their findings were published in the scientific journal Neuroscience.
Early diagnosis of Alzheimer’s disease has always been difficult. Many of the early signs of the disease, such as forgetfulness or mild confusion, can look very similar to normal aging.
As people grow older, it is common to occasionally forget names, misplace items, or struggle to recall details. Because these changes can seem harmless, the early stages of Alzheimer’s disease often go unnoticed for years.
Benjamin Nephew, an assistant research professor in the Department of Biology and Biotechnology at WPI, explained that this uncertainty makes diagnosis challenging. According to him, artificial intelligence tools can help solve this problem because they are able to analyze enormous amounts of medical data and identify patterns that humans might miss.
Artificial intelligence works by using computer systems that learn from data. In medicine, machine-learning programs can study thousands of medical images and gradually learn what healthy tissue looks like and how it differs from diseased tissue. Once trained, these systems can examine new scans and predict whether signs of disease are present.
For this study, Nephew and his research team used magnetic resonance imaging scans, commonly known as MRI scans. MRI is a technology that creates detailed pictures of the inside of the body, including the brain. These images allow doctors and scientists to see the structure of different brain regions and measure their size and shape.
The researchers used MRI data collected by the Alzheimer’s Disease Neuroimaging Initiative. This large international project has gathered brain scans and medical information from thousands of people in order to better understand how Alzheimer’s disease develops. The dataset used in this study included brain scans from adults between the ages of 69 and 84.
Some of the participants had normal brain function, while others had mild cognitive impairment. Mild cognitive impairment is often considered an early stage that can sometimes lead to Alzheimer’s disease. The dataset also included people who had already been diagnosed with Alzheimer’s disease.
Analyzing MRI scans can be very complicated because each scan contains a large amount of information. To make the process manageable, the WPI researchers first used machine learning to measure the volume of 95 different brain regions across 815 MRI scans. Brain volume refers to the size of specific structures within the brain.
After collecting these measurements, the researchers used another algorithm to compare the brain structures of healthy individuals with those of people who had mild cognitive impairment or Alzheimer’s disease. By studying the differences in brain volume, the system learned to recognize patterns linked to the disease.
The results were impressive. The artificial intelligence system was able to identify Alzheimer’s disease with an accuracy of 92.87 percent when comparing healthy brains with those affected by mild cognitive impairment or Alzheimer’s disease.
The study also revealed important clues about which parts of the brain are most affected. The researchers found that three areas were especially strong indicators of Alzheimer’s disease: the hippocampus, the amygdala, and the entorhinal cortex.
The hippocampus plays a central role in forming and storing memories. It is shaped somewhat like a small seahorse and lies deep within the brain. Damage to this region is strongly linked to memory loss, which is one of the most recognizable symptoms of Alzheimer’s disease.
The amygdala is involved in emotional processing. It helps the brain recognize emotions such as fear, happiness, and stress. The entorhinal cortex acts as a connection hub that links memory, navigation, and perception. Scientists have long known that this region is one of the first areas affected when Alzheimer’s disease begins.
The researchers discovered that loss of brain volume in these regions was a strong predictor of Alzheimer’s disease across different groups of people. Interestingly, they also found patterns related to age and sex.
Among both men and women aged 69 to 76, the earliest signs of brain shrinkage were found in the right hippocampus. This suggests that this specific brain region may be especially important for detecting the disease during its earliest stages.
The study also found differences between male and female brains. In women, the researchers observed greater volume loss in a region called the left middle temporal cortex, which helps with language, memory, and visual understanding. In men, the most noticeable changes appeared in the right entorhinal cortex.
These differences surprised the researchers and may be related to changes in sex hormones that occur as people age. Some scientists believe that declining estrogen levels in women and declining testosterone levels in men may influence how Alzheimer’s disease develops in the brain.
The researchers emphasized that building reliable artificial intelligence models is one of the biggest challenges in this field. For a model to be useful in real medical settings, it must work well for many different patients, not just for the data used to train it. The team hopes that the brain patterns they discovered may represent universal markers of Alzheimer’s disease.
Looking ahead, the WPI research group plans to continue exploring the use of advanced deep learning systems. They also plan to investigate other health conditions that might influence Alzheimer’s disease, including diabetes and metabolic disorders.
The project has already attracted students from many scientific fields, including biology, neuroscience, psychology, computer science, and bioinformatics.
When examining the findings overall, the study provides encouraging evidence that artificial intelligence could become a powerful tool in diagnosing brain diseases earlier and more accurately. However, it is important to remember that these systems still need further testing in hospitals and clinics before they become part of routine medical care.
One of the most important insights from this research is that Alzheimer’s disease leaves physical traces in the brain long before severe symptoms appear. By detecting small changes in brain structure early, doctors may eventually be able to begin treatment sooner and slow the progression of the disease.
At the same time, the study highlights how complex Alzheimer’s disease truly is. Differences related to age, sex, hormones, and other health conditions all appear to influence how the disease develops. This means that future treatments may need to be personalized rather than identical for every patient.
Overall, the research demonstrates how combining neuroscience with artificial intelligence may open new possibilities for understanding the brain.
As technology continues to improve, tools like machine learning may help doctors detect diseases earlier, guide treatment decisions, and ultimately improve the lives of millions of people affected by Alzheimer’s disease.
If you care about Alzheimer’s disease, please read studies about the protective power of dietary antioxidants against Alzheimer’s, and eating habits linked to higher Alzheimer’s risk.
For more health information, please see recent studies that oral cannabis extract may help reduce Alzheimer’s symptoms, and Vitamin E may help prevent Parkinson’s disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
